Atossa Genetics Aktie
WKN DE: A2JJ99 / ISIN: US04962H5063
12.08.2025 15:53:56
|
Atossa Therapeutics Inc. Q2 Loss Increases, Misses Estimates
(RTTNews) - Atossa Therapeutics Inc. (ATOS) revealed Loss for its second quarter that increased from last year and missed the Street estimates.
The company's earnings totaled -$8.42 million, or -$0.07 per share. This compares with -$6.05 million, or -$0.05 per share, last year.
Analysts on average had expected the company to earn -$0.06 per share. Analysts' estimates typically exclude special items.
Atossa Therapeutics Inc. earnings at a glance (GAAP) :
-Earnings: -$8.42 Mln. vs. -$6.05 Mln. last year. -EPS: -$0.07 vs. -$0.05 last year.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Atossa Genetics Inc Registered Shsmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Atossa Genetics Inc Registered Shsmehr Analysen
Aktien in diesem Artikel
Atossa Genetics Inc Registered Shs | 0,74 | 5,76% |
|